C3.ai Q1 Earnings: Revenue Miss, EPS Miss, CEO Transition — 'Completely Unacceptable' - C3.ai (NYSE:AI)
The lawsuit alleges C3.ai misled investors by understating CEO health issues and sales challenges, resulting in a 25% share price drop after missing revenue targets, according to Hagens Berman.
8 Articles
8 Articles
C3.AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of ...
NEW ORLEANS, Sept. 03, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 21, 2025 to file lead plaintiff applications in a securities class action lawsuit against C3.ai, Inc. (“C3” or the…


Robbins LLP Reminds NUTX Investors with Large Losses of the Pending Class Action Against Nutex ...
SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Nutex Health Inc. (NASDAQ: NUTX) securities between August 8, 2024 and…


C3.ai, Inc. (AI) Hit With Securities Class Action After Shares Crash 25% On Large Revenue Miss -- Hagens Berman
/PRNewswire/ -- A securities fraud class action lawsuit styled Liggett Sr. v. C3.ai, Inc., et al., No. 3:25-cv-07129 (N.D. Cal.) has been filed and seeks to...
C3.AI INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that C3.ai, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
SAN DIEGO, Sept. 3, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that the C3.ai class action lawsuit – captioned Liggett v. C3.ai, Inc., No. 25-cv-07129 (N.D. Cal.) – seeks to represent purchasers or acquirers of C3.ai, Inc.…
Coverage Details
Bias Distribution
- 83% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium